ET
Eirion Therapeutics is a clinical-stage biopharmaceutical company developing next-generation prescription products that target specific disease pathways using advanced drug delivery systems. Their focus is on improving patient outcomes by enhancing the efficacy and safety profiles of existing therapies.
Updated 4 months ago
Funding
$43M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Eirion Therapeutics is a clinical-stage biopharmaceutical company developing next-generation prescription products that target specific disease pathways using advanced drug delivery systems. Their focus is on improving patient outcomes by enhancing the efficacy and safety profiles of existing therapies.